NCT02677961

Brief Summary

Translational studies in cancer research can be impeded by the lack of high-quality clinical data that can be correlated with research questions. This is particularly true in the case of rare diseases, such as bone and soft tissue tumors. It is therefore the purpose of this study to create a prospective EHR-based clinical registry for individuals with bone and soft-tissue tumors.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started Jul 2015

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Jul 2015Dec 2027

Study Start

First participant enrolled

July 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 9, 2016

Completed
11.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

12.5 years

First QC Date

February 5, 2016

Last Update Submit

February 9, 2026

Conditions

Neoplasms, Connective and Soft TissueBone Neoplasms

Keywords

sarcomaregistry

Outcome Measures

Primary Outcomes (1)

  • Overall Survival

    5 Years

Interventions

ObservationOTHER

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with a diagnosis of bone or soft-tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)

You may qualify if:

  • Must have a diagnosis or presumed diagnosis of bone or soft tissue tumor as defined by the WHO classification of tumors of soft tissue and bone (4th ed.)
  • Patient, or his/her designated power of attorney, must be able to understand and approve of the consent to participate.

You may not qualify if:

  • Prisoners are excluded from participation in the Registry.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio State University

Columbus, Ohio, 43210, United States

RECRUITING

Related Links

MeSH Terms

Conditions

Neoplasms, Connective and Soft TissueBone NeoplasmsSarcoma

Interventions

Observation

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsNeoplasms by SiteBone DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • David A Liebner, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Erin Fetzer

CONTACT

erin.fetzer@osumc.edu

David A Liebner, MD

CONTACT

(614) 293-2886David.Liebner@osumc.edu

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 5, 2016

First Posted

February 9, 2016

Study Start

July 1, 2015

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

February 11, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations

US(1)